Back to search

Article

Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron

2022-01-24

Abstract excerpt

<h4>SUMMARY</h4> Although vaccines and monoclonal antibody countermeasures have reduced the morbidity and mortality associated with SARS-CoV-2 infection, variants with constellations of mutations in the spike gene threaten their efficacy. Accordingly, antiviral interventions that are resistant to further virus evolution are needed. The host-derived cytokine IFN-λ has been proposed as a possible treatment based on...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d54ebb3-9b3b-5ebe-9090-bdcfeb1e4730
DOI
10.1101/2022.01.21.477296
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including OmicronDOI 10.1101/2022.01.21.477296
Select a neighboring publication to make it the new centre.